| Name | 6-(2-methylbut-3-en-2-yl)furo[3,2-g]chromen-7-one |
|---|---|
| Synonyms |
Xyloltenin
Chalepensin |
| Description | Chalepensin, a furanocoumarin, is a competitive CYP2A6 inhibitor. Chalepensin also inhibits human CYP1A1, CYP1A2, CYP2A13, CYP2C9, CYP2D6, CYP2E1, and CYP3A4 to different extents[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.211g/cm3 |
|---|---|
| Boiling Point | 390.5ºC at 760mmHg |
| Molecular Formula | C16H14O3 |
| Molecular Weight | 254.28100 |
| Flash Point | 190ºC |
| Exact Mass | 254.09400 |
| PSA | 43.35000 |
| LogP | 4.00280 |
| Vapour Pressure | 2.64E-06mmHg at 25°C |
| Index of Refraction | 1.606 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2932999099 |
|---|
| HS Code | 2932999099 |
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |